FDA issued a Warning Letter to Hospira, Inc. on 3/7/2014 for a previous inspection.
483 Hospira Feb 2018

483 Hospira Feb 2018

Claudette Brooks FDA, Bonita Chester FDA, Sayeeda Hdabe FDA, Tamara Henderson FDA, Lesley Satterwhite FDA$119.00 - Available Now

FDA investigators audited the Hospira - Rocky Mount, NC, United States facility and issued inspectional observations (via FDA 483) on 02 Feb 2018.

Product details

  • Category: Medical Devices & Rad Health / Human Drugs
  • Inspection end: 02 Feb 2018
  • Location: Rocky Mount, United States
  • FEI: 1021343
Add To Cart